Therapies / NASDAQ / Clinical / Therapeutics / News / Syndication / Nasdaq / ONCTUS68236P1075

Oncternal Therapeutics Reports Granting of an Inducement Award Under Nasdaq Listing Rule 5635(4)

Posted on: Feb 23, 2021   |   Posted by: Biotech Mag

SAN DIEGO, Feb. 22, 2021 - Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced...




Other Posts from Biotech Mag